BACKGROUND: The remodeling of vein bypass grafts after arterialization is incompletely understood. We have previously shown that significant outward lumen remodeling occurs during the first month of implantation, but the magnitude of this response is highly variable. We sought to examine the hypothesis that systemic inflammation influences this early remodeling response. METHODS: A prospective observational study was done of 75 patients undergoing lower extremity bypass using autogenous vein. Graft remodeling was assessed using a combination of ultrasound imaging and two-dimensional high-resolution magnetic resonance imaging. RESULTS: The vein graft lumen diameter change from 0 to 1 month (22.7% median increase) was positively correlated with initial shear stress (P = .016), but this shear-dependent response was disrupted in subjects with an elevated baseline high-sensitivity C-reactive protein (hsCRP) level of >5 mg/L. Despite similar vein diameter and shear stress at implantation, grafts in the elevated hsCRP group demonstrated less positive remodeling from 0 to 1 month (13.5% vs 40.9%, P = .0072). By regression analysis, the natural logarithm of hsCRP was inversely correlated with 0- to 1-month lumen diameter change (P = .018). Statin therapy (beta = 23.1, P = .037), hsCRP (beta = -29.7, P = .006), and initial shear stress (beta = .85, P = .003) were independently correlated with early vein graft remodeling. In contrast, wall thickness at 1 month was not different between hsCRP risk groups. Grafts in the high hsCRP group tended to be stiffer at 1 month, as reflected by a higher calculated elastic modulus (E = 50.4 vs 25.1 Mdynes/cm2, P = .07). CONCLUSIONS: Early positive remodeling of vein grafts is a shear-dependent response that is modulated by systemic inflammation. These data suggest that baseline inflammation influences vein graft healing, and therefore, inflammation may be a relevant therapeutic target to improve early vein graft adaptation.
BACKGROUND: The remodeling of vein bypass grafts after arterialization is incompletely understood. We have previously shown that significant outward lumen remodeling occurs during the first month of implantation, but the magnitude of this response is highly variable. We sought to examine the hypothesis that systemic inflammation influences this early remodeling response. METHODS: A prospective observational study was done of 75 patients undergoing lower extremity bypass using autogenous vein. Graft remodeling was assessed using a combination of ultrasound imaging and two-dimensional high-resolution magnetic resonance imaging. RESULTS: The vein graft lumen diameter change from 0 to 1 month (22.7% median increase) was positively correlated with initial shear stress (P = .016), but this shear-dependent response was disrupted in subjects with an elevated baseline high-sensitivity C-reactive protein (hsCRP) level of >5 mg/L. Despite similar vein diameter and shear stress at implantation, grafts in the elevated hsCRP group demonstrated less positive remodeling from 0 to 1 month (13.5% vs 40.9%, P = .0072). By regression analysis, the natural logarithm of hsCRP was inversely correlated with 0- to 1-month lumen diameter change (P = .018). Statin therapy (beta = 23.1, P = .037), hsCRP (beta = -29.7, P = .006), and initial shear stress (beta = .85, P = .003) were independently correlated with early vein graft remodeling. In contrast, wall thickness at 1 month was not different between hsCRP risk groups. Grafts in the high hsCRP group tended to be stiffer at 1 month, as reflected by a higher calculated elastic modulus (E = 50.4 vs 25.1 Mdynes/cm2, P = .07). CONCLUSIONS: Early positive remodeling of vein grafts is a shear-dependent response that is modulated by systemic inflammation. These data suggest that baseline inflammation influences vein graft healing, and therefore, inflammation may be a relevant therapeutic target to improve early vein graft adaptation.
Authors: George T Lau; Lloyd J Ridley; Paul G Bannon; Louise A Wong; Joseph Trieu; David B Brieger; Harry C Lowe; Ben S Freedman; Leonard Kritharides Journal: Circulation Date: 2006-07-04 Impact factor: 29.690
Authors: Daniel A Caños; Gary S Mintz; Chalak O Berzingi; Sue Apple; Jun-ichi Kotani; Augusto D Pichard; Lowell F Satler; William O Suddath; Ron Waksman; Joseph Lindsay; Neil J Weissman Journal: J Am Coll Cardiol Date: 2004-07-07 Impact factor: 24.094
Authors: Aziz Momin; Narbeh Melikian; Stephen B Wheatcroft; David Grieve; Lindsay C John; Ahmad El Gamel; Michael T Marrinan; Jatin B Desai; Catherine Driver; Roy Sherwood; Ajay M Shah; Mark T Kearney Journal: J Thorac Cardiovasc Surg Date: 2007-08 Impact factor: 5.209
Authors: Daniel Y Lu; Elizabeth Y Chen; Daniel J Wong; Kota Yamamoto; Clinton D Protack; Willis T Williams; Roland Assi; Michael R Hall; Nirvana Sadaghianloo; Alan Dardik Journal: J Surg Res Date: 2014-01-30 Impact factor: 2.192
Authors: Dimitris Mitsouras; Christopher D Owens; Michael S Conte; Hale Ersoy; Mark A Creager; Frank J Rybicki; Robert V Mulkern Journal: Magn Reson Med Date: 2009-09 Impact factor: 4.668
Authors: Michael S Conte; Christopher D Owens; Michael Belkin; Mark A Creager; Karen L Edwards; Warren J Gasper; Richard D Kenagy; Renee C LeBoeuf; Michael Sobel; Alexander Clowes Journal: J Vasc Surg Date: 2013-01-09 Impact factor: 4.268
Authors: Warren J Gasper; Christopher D Owens; Ji Min Kim; Nancy Hills; Michael Belkin; Mark A Creager; Michael S Conte Journal: J Vasc Surg Date: 2012-09-07 Impact factor: 4.268
Authors: Karen J Ho; Christopher D Owens; Thomas Longo; Xin X Sui; Cristos Ifantides; Michael S Conte Journal: Am J Physiol Heart Circ Physiol Date: 2008-07-11 Impact factor: 4.733